In the future, we will verify the efficacy of the vaccine in suitable animal models, if the result show that the G-GP vaccines can achieve protection, additional experiments, such as passive antibody and T cell transfer assays are required to demonstrate which of the antibody responses and/or CD4+, CD8+ T cell after vaccination/infection are responsible for surviving from CCHFV infection. Here, CD8A is linked to infection.